NUREXONE BIOLOGIC INC earnings per share and revenue

NRX earnings per share for the last quarter are -0.03 CAD whereas the estimation was -0.04 CAD which accounts for 33.33% surprise. Company revenue for the same period amounts to 0.00 CAD despite the estimated figure of 0.00 CAD. Estimated earnings per share for the next quarter are -0.03 CAD, and revenue is expected to reach 0.00 CAD. Also watch annual changes over time to get a bigger picture of NRX earnings per share and revenue dynamics.